K173763

Substantially Equivalent

iovera system

Applicant: Myoscience, Inc.
Product code: GXH
Advisory panel: Neurology
Date received: 2017-12-11
Decision date: 2018-02-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Fremont, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.